Need help finding what you are looking for?
Contact Us
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2058249
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2058249
Premature Ejaculation Treatment Market, By Drug Type, By Route of Administration, By Dosage Form, By Distribution Channel, By Geography
PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Premature Ejaculation Treatment Market is estimated to be valued at USD 3.2 Bn in 2026 and is expected to reach USD 5.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.2 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.90% | 2033 Value Projection: | USD 5.7 Bn |
Premature ejaculation also called as rapid ejaculation, premature climax or early ejaculation. It is a disorder, which causes early ejaculation of semen during sexual intercourse. Premature ejaculation is a very common problem, and its exact cause is not known. However, causes include early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.
Market Dynamics
Increasing launches of novel products for the treatment of premature ejaculation is expected to fuel the global premature ejaculation treatment market growth. For instance, in 2016, Regent Pacific Group Limited, a Hong Kong-based investment group, launched its product, Fortacin in the U.K. Fortacin is a topical spray, which contains low doses of two anesthetics - lidocaine and prilocaine and is indicated for the treatment of premature ejaculation. Furthermore, increasing prevalence of premature ejaculation due to unhealthy lifestyle and various factors such as depression and hormonal imbalance is expected to rise demand for premature ejaculation treatment drugs. For instance, according to the data published by National Center for BioDrug Type Information in 2016, around 25.8% of male in China are suffering from premature ejaculation.
Key features of the study
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
- It profiles leading players in the global premature ejaculation treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
- Key companies covered as a part of this study include Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScience, NeuroHealing Pharmaceuticals Inc., and Dong-A Pharmaceutical Co., Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technological up-gradation, market expansion, and marketing tactics
- The global premature ejaculation treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the premature ejaculation treatment market
Market Segmentation
- By Drug Type (Revenue, USD Bn, 2021-2033)
- Selective Serotonin Reuptake Inhibitors (SSRIs)
- Dapoxetine
- Others
- Phosphodiesterase Type 5 (PDE5) Inhibitors
- Zertane
- Others
- Topical Anesthetics
- Others
- By Route of Administration (Revenue, USD Bn, 2021-2033)
- Oral
- Topical
- By Dosage Form (Revenue, USD Bn, 2021-2033)
- Pills
- Spray
- Others
- By Distribution Channel (Revenue, USD Bn, 2021-2033)
- Hospitals
- Online Pharmacies
- Retail Pharmacies
- By Region (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Competitive Landscape
- Regent Pacific Group Limited
- Menarini Group
- Furiex Pharmaceuticals, Inc.
- Absorption Pharmaceuticals, LLC
- Ampio Pharmaceuticals, Inc.
- Aytu BioScience,
- NeuroHealing Pharmaceuticals Inc.
- Dong-A Pharmaceutical Co., Ltd.
Product Code: CMI1956
Table of Contents
1. Research Objective and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Route of Administration
- Market Snippet, By Dosage Form
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- PEST Analysis
- Pipeline Analysis
- Product Approval
- Product Launch
- Collaboration-Acquisition
- Porter's Five Forces Analysis
4. Global Premature Ejaculation Treatment Market, By Drug Type, 2021 - 2033 (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Selective Serotonin Reuptake Inhibitors (SSRIs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Dapoxetine
- Others
- Phosphodiesterase Type 5 (PDE5) Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Zertane
- Others
- Topical Anesthetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Premature Ejaculation Treatment Market, By Route of Administration, 2021 - 2033 (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Premature Ejaculation Treatment Market, By Dosage Form, 2021 - 2033 (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Spray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Premature Ejaculation Treatment Market, By Distribution Channel, 2021 - 2033 (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Premature Ejaculation Treatment Market, By Region, 2021 - 2033 (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- North America
- Market Size and Forecast, By Drug Type, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033 (USD Bn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Drug Type, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033 (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Type, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033 (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Drug Type, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033 (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Drug Type, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033 (USD Bn)
- Central Africa
- South Africa
- North Africa
- Middle East
- Market Size and Forecast, By Drug Type, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033 (USD Bn)
- GCC
- Israel
- Rest of Middle East
9. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Regent Pacific Group Limited
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Menarini Group
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Furiex Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Absorption Pharmaceuticals, LLC
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ampio Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aytu BioScience
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NeuroHealing Pharmaceuticals Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dong-A Pharmaceutical Co., Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Regent Pacific Group Limited
10. Section
- References
- Research Methodology
- About us and Sales Contact
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.